Diabetic Neuropathy: A Position Statement by the @AmDiabetesAssn

Here is the latest position statement from our friends and colleagues Rodica Pop-Busui, Andrew Boulton, et al.  Enjoy.

Introduction

Diabetic neuropathies are the most prevalent chronic complications of diabetes. This heterogeneous group of conditions affects different parts of the nervous system and presents with diverse clinical manifestations. The early recognition and appropriate management of neuropathy in the patient with diabetes is important for a number of reasons:

  1. Diabetic neuropathy is a diagnosis of exclusion. Nondiabetic neuropathies may be present in patients with diabetes and may be treatable by specific measures.

  2. A number of treatment options exist for symptomatic diabetic neuropathy.

  3. Up to 50% of diabetic peripheral neuropathies may be asymptomatic. If not recognized and if preventive foot care is not implemented, patients are at risk for injuries to their insensate feet.

  4. Recognition and treatment of autonomic neuropathy may improve symptoms, reduce sequelae, and improve quality of life.

Among the various forms of diabetic neuropathy, distal symmetric polyneuropathy (DSPN) and diabetic autonomic neuropathies, particularly cardiovascular autonomic neuropathy (CAN), are by far the most studied (14). There are several atypical forms of diabetic neuropathy as well (14). Patients with prediabetes may also develop neuropathies that are similar to diabetic neuropathies (510). Table 1 provides a comprehensive classification scheme for the diabetic neuropathies.

For more, see source, below.

Source: Diabetes Care

David G. Armstrong

Dedicated to amputation prevention, wound healing, diabetic foot, biotechnology and the intersection between medical devices and consumer electronics.

Leave a Reply